

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87203333 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49366886 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49366886 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.30650009 |
| 5 | negative regulation of cell killing (GO:0031342) | 4.92744738 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.92744738 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.78157864 |
| 8 | negative thymic T cell selection (GO:0045060) | 4.78053999 |
| 9 | negative T cell selection (GO:0043383) | 4.77405718 |
| 10 | leukocyte aggregation (GO:0070486) | 4.73601276 |
| 11 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.64706736 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.62957973 |
| 13 | positive thymic T cell selection (GO:0045059) | 4.58138071 |
| 14 | detection of other organism (GO:0098543) | 4.30792781 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 4.29570287 |
| 16 | interferon-gamma production (GO:0032609) | 4.29087601 |
| 17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.24638208 |
| 18 | macrophage activation involved in immune response (GO:0002281) | 4.18488867 |
| 19 | detection of bacterium (GO:0016045) | 4.09483713 |
| 20 | thymic T cell selection (GO:0045061) | 4.07916773 |
| 21 | B cell receptor signaling pathway (GO:0050853) | 4.05498363 |
| 22 | T cell migration (GO:0072678) | 4.02067676 |
| 23 | response to interleukin-15 (GO:0070672) | 3.98943960 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.98361627 |
| 25 | negative regulation of T cell mediated immunity (GO:0002710) | 3.91087681 |
| 26 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.90796379 |
| 27 | tolerance induction (GO:0002507) | 3.87983068 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.81393985 |
| 29 | response to peptidoglycan (GO:0032494) | 3.81084598 |
| 30 | regulation of B cell differentiation (GO:0045577) | 3.81064568 |
| 31 | T cell selection (GO:0045058) | 3.76760461 |
| 32 | detection of external biotic stimulus (GO:0098581) | 3.75686289 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 3.72940605 |
| 34 | positive T cell selection (GO:0043368) | 3.71227810 |
| 35 | regulation of T cell tolerance induction (GO:0002664) | 3.68009849 |
| 36 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.66935205 |
| 37 | cellular response to interleukin-15 (GO:0071350) | 3.65862316 |
| 38 | activated T cell proliferation (GO:0050798) | 3.64021798 |
| 39 | positive regulation of B cell differentiation (GO:0045579) | 3.62725989 |
| 40 | cellular extravasation (GO:0045123) | 3.59835014 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.59593844 |
| 42 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57767788 |
| 43 | response to host immune response (GO:0052572) | 3.57767788 |
| 44 | microglial cell activation (GO:0001774) | 3.55986026 |
| 45 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.55260041 |
| 46 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.54108248 |
| 47 | modulation by symbiont of host immune response (GO:0052553) | 3.54108248 |
| 48 | positive regulation by symbiont of host defense response (GO:0052509) | 3.54108248 |
| 49 | modulation by symbiont of host defense response (GO:0052031) | 3.54108248 |
| 50 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.54108248 |
| 51 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.54108248 |
| 52 | T cell costimulation (GO:0031295) | 3.49615126 |
| 53 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.43675152 |
| 54 | lymphocyte costimulation (GO:0031294) | 3.43511554 |
| 55 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.41163316 |
| 56 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.38683738 |
| 57 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.37833709 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.37004819 |
| 59 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.36756979 |
| 60 | positive regulation of granulocyte differentiation (GO:0030854) | 3.33992533 |
| 61 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.33210667 |
| 62 | neutrophil activation (GO:0042119) | 3.32400865 |
| 63 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.32075477 |
| 64 | response to host (GO:0075136) | 3.32075477 |
| 65 | response to host defenses (GO:0052200) | 3.32075477 |
| 66 | detection of biotic stimulus (GO:0009595) | 3.28535301 |
| 67 | respiratory burst (GO:0045730) | 3.27303280 |
| 68 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.23330128 |
| 69 | mast cell activation (GO:0045576) | 3.22822376 |
| 70 | positive regulation of interleukin-2 production (GO:0032743) | 3.22417192 |
| 71 | germinal center formation (GO:0002467) | 3.21571900 |
| 72 | immunoglobulin mediated immune response (GO:0016064) | 3.20793253 |
| 73 | negative regulation of phagocytosis (GO:0050765) | 3.20319815 |
| 74 | T cell receptor signaling pathway (GO:0050852) | 3.17888321 |
| 75 | positive regulation of isotype switching (GO:0045830) | 3.17814196 |
| 76 | leukocyte cell-cell adhesion (GO:0007159) | 3.16875624 |
| 77 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.16388978 |
| 78 | macrophage activation (GO:0042116) | 3.15241356 |
| 79 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.14544499 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 3.13067669 |
| 81 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.12876007 |
| 82 | granulocyte activation (GO:0036230) | 3.09541062 |
| 83 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.09490425 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 3.09141883 |
| 85 | B cell mediated immunity (GO:0019724) | 3.05990717 |
| 86 | positive regulation of antigen processing and presentation (GO:0002579) | 3.05660079 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.05465213 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 3.01490873 |
| 89 | leukocyte degranulation (GO:0043299) | 3.00582155 |
| 90 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.00561008 |
| 91 | defense response to protozoan (GO:0042832) | 2.98939251 |
| 92 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.97706532 |
| 93 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.97706532 |
| 94 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.97669919 |
| 95 | regulation of tolerance induction (GO:0002643) | 2.96961905 |
| 96 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.95013862 |
| 97 | positive regulation of tolerance induction (GO:0002645) | 2.93366210 |
| 98 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.93151509 |
| 99 | T cell proliferation (GO:0042098) | 2.93059763 |
| 100 | myeloid dendritic cell differentiation (GO:0043011) | 2.91951589 |
| 101 | T cell homeostasis (GO:0043029) | 2.91872346 |
| 102 | mature B cell differentiation (GO:0002335) | 2.91215605 |
| 103 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.90741964 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.89941497 |
| 105 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.89390148 |
| 106 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.88334852 |
| 107 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.87766904 |
| 108 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.86788657 |
| 109 | regulation of mast cell activation (GO:0033003) | 2.86556552 |
| 110 | neutrophil mediated immunity (GO:0002446) | 2.86237150 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.85511804 |
| 112 | natural killer cell activation (GO:0030101) | 2.84037386 |
| 113 | response to type I interferon (GO:0034340) | 2.83866705 |
| 114 | NIK/NF-kappaB signaling (GO:0038061) | 2.83801738 |
| 115 | positive regulation of macrophage differentiation (GO:0045651) | 2.83669550 |
| 116 | myeloid cell activation involved in immune response (GO:0002275) | 2.81832324 |
| 117 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.81462261 |
| 118 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.81462261 |
| 119 | * immune response-activating cell surface receptor signaling pathway (GO:0002429) | 2.81252822 |
| 120 | negative regulation of B cell proliferation (GO:0030889) | 2.80996801 |
| 121 | regulation of interferon-alpha production (GO:0032647) | 2.79985269 |
| 122 | positive regulation of interferon-alpha production (GO:0032727) | 2.78185595 |
| 123 | cellular response to type I interferon (GO:0071357) | 2.77884116 |
| 124 | type I interferon signaling pathway (GO:0060337) | 2.77884116 |
| 125 | response to protozoan (GO:0001562) | 2.76334037 |
| 126 | response to muramyl dipeptide (GO:0032495) | 2.76073575 |
| 127 | regulation of regulatory T cell differentiation (GO:0045589) | 2.74126802 |
| 128 | lymphocyte homeostasis (GO:0002260) | 2.73206983 |
| 129 | response to laminar fluid shear stress (GO:0034616) | 2.72309932 |
| 130 | positive regulation of B cell mediated immunity (GO:0002714) | 2.71697310 |
| 131 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.71697310 |
| 132 | positive regulation of mast cell activation (GO:0033005) | 2.70791439 |
| 133 | regulation of antigen processing and presentation (GO:0002577) | 2.70093205 |
| 134 | cellular response to zinc ion (GO:0071294) | 2.69185009 |
| 135 | pinocytosis (GO:0006907) | 2.68756714 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.68461379 |
| 137 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.68000952 |
| 138 | positive regulation of DNA recombination (GO:0045911) | 2.67932328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 6.17939341 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.75238800 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.64583027 |
| 4 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.10430673 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.98787059 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.59491105 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.50134871 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.27386638 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.20903198 |
| 10 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.11703360 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.10264939 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 3.08639968 |
| 13 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 3.01692117 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.96330206 |
| 15 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.93000207 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.89594662 |
| 17 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.83704089 |
| 18 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.83160640 |
| 19 | * MYB_26560356_Chip-Seq_TH2_Human | 2.80274640 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.77129010 |
| 21 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76756150 |
| 22 | MAF_26560356_Chip-Seq_TH1_Human | 2.71988801 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.71627182 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.58668046 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.53659557 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.40460379 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34132480 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 2.29464671 |
| 29 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.25451471 |
| 30 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.20518105 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16276633 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.08871933 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.07701217 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.03211929 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.02558870 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.92307553 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91004570 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.90785160 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90297641 |
| 40 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.89360345 |
| 41 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.87375461 |
| 42 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.80732023 |
| 43 | MAF_26560356_Chip-Seq_TH2_Human | 1.77337340 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.71976367 |
| 45 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.71719192 |
| 46 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.61830624 |
| 47 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.59820254 |
| 48 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59508963 |
| 49 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58393159 |
| 50 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.57757462 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48949866 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.45039658 |
| 53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.44490488 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43990864 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.39423532 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.34877775 |
| 57 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34450457 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.28260072 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26846989 |
| 60 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.26353726 |
| 61 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26039679 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25500192 |
| 63 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.23676260 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22736347 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.20917123 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17692346 |
| 67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.17136987 |
| 68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.12922527 |
| 69 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11539434 |
| 70 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10971361 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.10727920 |
| 72 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10322461 |
| 73 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.09065340 |
| 74 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99390086 |
| 75 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.99102478 |
| 76 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.98859172 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98356203 |
| 78 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97776957 |
| 79 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97010100 |
| 80 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.96376730 |
| 81 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95142307 |
| 82 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.94507310 |
| 83 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94027678 |
| 84 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93319550 |
| 85 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91482082 |
| 86 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90682853 |
| 87 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90585706 |
| 88 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90469696 |
| 89 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.89572395 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89095812 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.88985816 |
| 92 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88604592 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.86250418 |
| 94 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83239119 |
| 95 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.82433044 |
| 96 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.82060251 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81759577 |
| 98 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.81581897 |
| 99 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80429115 |
| 100 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.79762257 |
| 101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.79621755 |
| 102 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.78422672 |
| 103 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.77997933 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.75756824 |
| 105 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75744099 |
| 106 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.74765150 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.73997205 |
| 108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.73984308 |
| 109 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73599576 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72074916 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71939808 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.70967080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.99813208 |
| 2 | MP0005671_abnormal_response_to | 3.46284547 |
| 3 | MP0005387_immune_system_phenotype | 3.33138043 |
| 4 | MP0001790_abnormal_immune_system | 3.33138043 |
| 5 | MP0003303_peritoneal_inflammation | 3.32695216 |
| 6 | MP0000685_abnormal_immune_system | 3.28203295 |
| 7 | * MP0001800_abnormal_humoral_immune | 3.19428356 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.06137315 |
| 9 | MP0003436_decreased_susceptibility_to | 2.99160965 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.92373710 |
| 11 | * MP0002452_abnormal_antigen_presenting | 2.82734229 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.70843083 |
| 13 | * MP0002723_abnormal_immune_serum | 2.70720744 |
| 14 | * MP0002420_abnormal_adaptive_immunity | 2.68815660 |
| 15 | * MP0001819_abnormal_immune_cell | 2.65756352 |
| 16 | MP0006082_CNS_inflammation | 2.61802378 |
| 17 | MP0009785_altered_susceptibility_to | 2.60611084 |
| 18 | MP0005025_abnormal_response_to | 2.58693903 |
| 19 | MP0002419_abnormal_innate_immunity | 2.50685289 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.46290861 |
| 21 | * MP0002398_abnormal_bone_marrow | 2.36215215 |
| 22 | MP0002405_respiratory_system_inflammati | 2.31788224 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.21672268 |
| 24 | * MP0000716_abnormal_immune_system | 2.21550616 |
| 25 | MP0002166_altered_tumor_susceptibility | 2.21232457 |
| 26 | MP0003724_increased_susceptibility_to | 2.16118441 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.16034539 |
| 28 | MP0004510_myositis | 2.06502895 |
| 29 | MP0001873_stomach_inflammation | 2.04952891 |
| 30 | MP0000689_abnormal_spleen_morphology | 1.98284778 |
| 31 | MP0009278_abnormal_bone_marrow | 1.95343616 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.92635933 |
| 33 | * MP0002722_abnormal_immune_system | 1.89741368 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.85056671 |
| 35 | * MP0002429_abnormal_blood_cell | 1.81755280 |
| 36 | MP0000465_gastrointestinal_hemorrhage | 1.80234791 |
| 37 | MP0002933_joint_inflammation | 1.75732256 |
| 38 | MP0002006_tumorigenesis | 1.73099266 |
| 39 | MP0008260_abnormal_autophagy | 1.71826601 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.71022742 |
| 41 | MP0004947_skin_inflammation | 1.70775673 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.69673001 |
| 43 | * MP0000703_abnormal_thymus_morphology | 1.68746902 |
| 44 | MP0005058_abnormal_lysosome_morphology | 1.64795848 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.62644571 |
| 46 | MP0003448_altered_tumor_morphology | 1.55749294 |
| 47 | MP0005310_abnormal_salivary_gland | 1.55619363 |
| 48 | MP0001853_heart_inflammation | 1.52630037 |
| 49 | MP0001545_abnormal_hematopoietic_system | 1.47957798 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.47957798 |
| 51 | MP0003866_abnormal_defecation | 1.46731767 |
| 52 | MP0005451_abnormal_body_composition | 1.36278863 |
| 53 | MP0001851_eye_inflammation | 1.29336564 |
| 54 | MP0000858_altered_metastatic_potential | 1.23690567 |
| 55 | MP0004883_abnormal_blood_vessel | 1.23666552 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.16055092 |
| 57 | MP0008469_abnormal_protein_level | 1.15272520 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.11769318 |
| 59 | MP0000490_abnormal_crypts_of | 1.11040149 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.10267901 |
| 61 | MP0000343_altered_response_to | 1.10134292 |
| 62 | MP0008004_abnormal_stomach_pH | 1.04608787 |
| 63 | MP0000920_abnormal_myelination | 1.02962478 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.00358938 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 0.99264156 |
| 66 | MP0005174_abnormal_tail_pigmentation | 0.99218185 |
| 67 | MP0000569_abnormal_digit_pigmentation | 0.98875467 |
| 68 | MP0003091_abnormal_cell_migration | 0.96878349 |
| 69 | MP0005023_abnormal_wound_healing | 0.92306132 |
| 70 | MP0005164_abnormal_response_to | 0.90093635 |
| 71 | MP0003828_pulmonary_edema | 0.89564637 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 0.86979959 |
| 73 | MP0003566_abnormal_cell_adhesion | 0.86935688 |
| 74 | MP0003279_aneurysm | 0.85286670 |
| 75 | MP0008057_abnormal_DNA_replication | 0.84246282 |
| 76 | MP0002019_abnormal_tumor_incidence | 0.83515830 |
| 77 | MP0005390_skeleton_phenotype | 0.82361618 |
| 78 | MP0008438_abnormal_cutaneous_collagen | 0.80366811 |
| 79 | MP0004130_abnormal_muscle_cell | 0.77801556 |
| 80 | MP0003045_fibrosis | 0.77559643 |
| 81 | MP0000733_abnormal_muscle_development | 0.76334139 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.76277631 |
| 83 | MP0003453_abnormal_keratinocyte_physiol | 0.75556042 |
| 84 | MP0003191_abnormal_cellular_cholesterol | 0.74521949 |
| 85 | MP0010307_abnormal_tumor_latency | 0.74316957 |
| 86 | MP0000249_abnormal_blood_vessel | 0.73637033 |
| 87 | MP0009764_decreased_sensitivity_to | 0.70505793 |
| 88 | MP0003795_abnormal_bone_structure | 0.68078492 |
| 89 | MP0005166_decreased_susceptibility_to | 0.67074946 |
| 90 | MP0003075_altered_response_to | 0.67039059 |
| 91 | MP0001958_emphysema | 0.66793772 |
| 92 | MP0001663_abnormal_digestive_system | 0.66493232 |
| 93 | MP0000767_abnormal_smooth_muscle | 0.66099245 |
| 94 | MP0009763_increased_sensitivity_to | 0.65279841 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.64211874 |
| 96 | MP0008874_decreased_physiological_sensi | 0.64150887 |
| 97 | MP0009840_abnormal_foam_cell | 0.63098921 |
| 98 | MP0006054_spinal_hemorrhage | 0.62819339 |
| 99 | MP0002009_preneoplasia | 0.61703583 |
| 100 | MP0003690_abnormal_glial_cell | 0.60395634 |
| 101 | MP0000604_amyloidosis | 0.59559792 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.56883790 |
| 103 | MP0002277_abnormal_respiratory_mucosa | 0.55271825 |
| 104 | MP0004185_abnormal_adipocyte_glucose | 0.54005353 |
| 105 | MP0004381_abnormal_hair_follicle | 0.53159065 |
| 106 | MP0005075_abnormal_melanosome_morpholog | 0.52223021 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.51433471 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.50940246 |
| 109 | MP0002132_abnormal_respiratory_system | 0.50661440 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.50378030 |
| 111 | MP0002136_abnormal_kidney_physiology | 0.49483990 |
| 112 | MP0001243_abnormal_dermal_layer | 0.48351946 |
| 113 | MP0002133_abnormal_respiratory_system | 0.47118567 |
| 114 | MP0005388_respiratory_system_phenotype | 0.47118567 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.46359936 |
| 116 | MP0009115_abnormal_fat_cell | 0.45537397 |
| 117 | MP0004484_altered_response_of | 0.44828716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.28512239 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.10607267 |
| 3 | Myositis (HP:0100614) | 4.46867303 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.44747507 |
| 5 | Chronic otitis media (HP:0000389) | 4.32914986 |
| 6 | Recurrent viral infections (HP:0004429) | 4.24697933 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.21322530 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.19891254 |
| 9 | Cellulitis (HP:0100658) | 4.00048526 |
| 10 | Recurrent bronchitis (HP:0002837) | 3.79363959 |
| 11 | IgM deficiency (HP:0002850) | 3.76752892 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.73675879 |
| 13 | Stomatitis (HP:0010280) | 3.61003521 |
| 14 | Agammaglobulinemia (HP:0004432) | 3.52589037 |
| 15 | Orchitis (HP:0100796) | 3.51030549 |
| 16 | * Meningitis (HP:0001287) | 3.49301288 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.46971916 |
| 18 | * T lymphocytopenia (HP:0005403) | 3.46738079 |
| 19 | Panhypogammaglobulinemia (HP:0003139) | 3.45514278 |
| 20 | * Abnormality of T cell number (HP:0011839) | 3.42826628 |
| 21 | Recurrent skin infections (HP:0001581) | 3.42407322 |
| 22 | Nasal polyposis (HP:0100582) | 3.36910618 |
| 23 | Pustule (HP:0200039) | 3.25950764 |
| 24 | Optic neuritis (HP:0100653) | 3.25411331 |
| 25 | Retrobulbar optic neuritis (HP:0100654) | 3.25411331 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.25247932 |
| 27 | Abnormality of the nasal mucosa (HP:0000433) | 3.18654828 |
| 28 | Recurrent cutaneous fungal infections (HP:0011370) | 3.16378175 |
| 29 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.16378175 |
| 30 | * Vasculitis (HP:0002633) | 3.12032880 |
| 31 | * Chronic obstructive pulmonary disease (HP:0006510) | 3.11359751 |
| 32 | * Obstructive lung disease (HP:0006536) | 3.11359751 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.10015464 |
| 34 | Autoimmune thrombocytopenia (HP:0001973) | 3.08520076 |
| 35 | * Abnormality of T cells (HP:0002843) | 3.07420787 |
| 36 | Increased IgM level (HP:0003496) | 2.94550150 |
| 37 | Lymphopenia (HP:0001888) | 2.89194783 |
| 38 | Leukocytosis (HP:0001974) | 2.89082034 |
| 39 | Autoimmune hemolytic anemia (HP:0001890) | 2.88956355 |
| 40 | Gastrointestinal stroma tumor (HP:0100723) | 2.86953057 |
| 41 | Colitis (HP:0002583) | 2.86313400 |
| 42 | * Gingival bleeding (HP:0000225) | 2.84784163 |
| 43 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.80413359 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.77459929 |
| 45 | Eosinophilia (HP:0001880) | 2.76240430 |
| 46 | * Inflammation of the large intestine (HP:0002037) | 2.74128025 |
| 47 | Verrucae (HP:0200043) | 2.72789581 |
| 48 | Papilloma (HP:0012740) | 2.72789581 |
| 49 | Purpura (HP:0000979) | 2.70740567 |
| 50 | * Urticaria (HP:0001025) | 2.70111804 |
| 51 | Thyroiditis (HP:0100646) | 2.69984076 |
| 52 | Severe combined immunodeficiency (HP:0004430) | 2.69532709 |
| 53 | Pulmonary infiltrates (HP:0002113) | 2.65495897 |
| 54 | * Gastrointestinal inflammation (HP:0004386) | 2.63334732 |
| 55 | Combined immunodeficiency (HP:0005387) | 2.61477226 |
| 56 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.60928130 |
| 57 | Hemoptysis (HP:0002105) | 2.59503345 |
| 58 | Emphysema (HP:0002097) | 2.57076792 |
| 59 | Abnormality of the fingertips (HP:0001211) | 2.56414380 |
| 60 | Abnormality of B cell number (HP:0010975) | 2.55142700 |
| 61 | B lymphocytopenia (HP:0010976) | 2.55142700 |
| 62 | Hematochezia (HP:0002573) | 2.54616846 |
| 63 | Vacuolated lymphocytes (HP:0001922) | 2.53404912 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.53196655 |
| 65 | Arterial thrombosis (HP:0004420) | 2.52551887 |
| 66 | Osteomyelitis (HP:0002754) | 2.51644070 |
| 67 | Increased IgE level (HP:0003212) | 2.50662564 |
| 68 | IgG deficiency (HP:0004315) | 2.50363097 |
| 69 | Thrombocytosis (HP:0001894) | 2.49944149 |
| 70 | Gingivitis (HP:0000230) | 2.49735749 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.47275658 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.45797475 |
| 73 | * Spontaneous hematomas (HP:0007420) | 2.42605932 |
| 74 | Peritonitis (HP:0002586) | 2.40209641 |
| 75 | Osteolytic defects of the hand bones (HP:0009699) | 2.39497152 |
| 76 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.39497152 |
| 77 | Hypochromic anemia (HP:0001931) | 2.38495574 |
| 78 | Granulocytopenia (HP:0001913) | 2.35723547 |
| 79 | Anorexia (HP:0002039) | 2.35270931 |
| 80 | Recurrent pneumonia (HP:0006532) | 2.34946080 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.34359332 |
| 82 | Interstitial pulmonary disease (HP:0006530) | 2.34093799 |
| 83 | Episodic fever (HP:0001954) | 2.33195244 |
| 84 | Papilledema (HP:0001085) | 2.32898128 |
| 85 | Petechiae (HP:0000967) | 2.32522538 |
| 86 | Increased density of long bones (HP:0006392) | 2.32472713 |
| 87 | Recurrent lower respiratory tract infections (HP:0002783) | 2.31513309 |
| 88 | Chronic diarrhea (HP:0002028) | 2.30228405 |
| 89 | IgA deficiency (HP:0002720) | 2.28229049 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.25167324 |
| 91 | Gangrene (HP:0100758) | 2.24286671 |
| 92 | Abnormality of the pleura (HP:0002103) | 2.24126464 |
| 93 | Viral hepatitis (HP:0006562) | 2.23425982 |
| 94 | Chronic sinusitis (HP:0011109) | 2.23046048 |
| 95 | Restrictive lung disease (HP:0002091) | 2.23036673 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.21038380 |
| 97 | Slow saccadic eye movements (HP:0000514) | 2.20142204 |
| 98 | Periodontitis (HP:0000704) | 2.19996579 |
| 99 | Abnormal platelet volume (HP:0011876) | 2.19424605 |
| 100 | Hypochromic microcytic anemia (HP:0004840) | 2.16670942 |
| 101 | Abnormality of the peritoneum (HP:0002585) | 2.15801218 |
| 102 | Joint swelling (HP:0001386) | 2.13531794 |
| 103 | Dysostosis multiplex (HP:0000943) | 2.12979478 |
| 104 | Spondylolisthesis (HP:0003302) | 2.11953787 |
| 105 | Increased mean platelet volume (HP:0011877) | 2.11875981 |
| 106 | Gastrointestinal infarctions (HP:0005244) | 2.10827503 |
| 107 | Fatigue (HP:0012378) | 2.09955401 |
| 108 | Menorrhagia (HP:0000132) | 2.08219561 |
| 109 | Hypergammaglobulinemia (HP:0010702) | 2.06481092 |
| 110 | Acute hepatic failure (HP:0006554) | 2.03394248 |
| 111 | * Encephalitis (HP:0002383) | 2.01647378 |
| 112 | Disinhibition (HP:0000734) | 1.99516127 |
| 113 | * Skin ulcer (HP:0200042) | 1.98389416 |
| 114 | Amaurosis fugax (HP:0100576) | 1.96884869 |
| 115 | * Epistaxis (HP:0000421) | 1.96713555 |
| 116 | Keratoconjunctivitis (HP:0001096) | 1.96178347 |
| 117 | Abnormality of the endocardium (HP:0004306) | 1.93705681 |
| 118 | * Chest pain (HP:0100749) | 1.93290373 |
| 119 | Vertigo (HP:0002321) | 1.90855979 |
| 120 | Abnormality of the prostate (HP:0008775) | 1.90688352 |
| 121 | Skin rash (HP:0000988) | 1.89882714 |
| 122 | * Pulmonary embolism (HP:0002204) | 1.89504674 |
| 123 | Myocardial infarction (HP:0001658) | 1.88802100 |
| 124 | Arthralgia (HP:0002829) | 1.87759393 |
| 125 | * Lymphoma (HP:0002665) | 1.87250607 |
| 126 | * Sepsis (HP:0100806) | 1.87219460 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.30106796 |
| 2 | TXK | 3.49517762 |
| 3 | BLK | 2.77736114 |
| 4 | PRPF4B | 2.66023798 |
| 5 | STK10 | 2.55463583 |
| 6 | JAK3 | 2.52594073 |
| 7 | EPHB1 | 2.49761946 |
| 8 | TYK2 | 2.31325513 |
| 9 | ITK | 2.26007491 |
| 10 | ZAP70 | 2.18487732 |
| 11 | MAP3K14 | 2.16551172 |
| 12 | IRAK4 | 2.02331541 |
| 13 | CSK | 2.00362775 |
| 14 | ERN1 | 1.96765839 |
| 15 | BTK | 1.96620877 |
| 16 | GRK6 | 1.90697943 |
| 17 | CSF1R | 1.83111136 |
| 18 | KIT | 1.83073038 |
| 19 | IKBKE | 1.82898413 |
| 20 | JAK1 | 1.82212219 |
| 21 | TBK1 | 1.82136484 |
| 22 | MAP3K10 | 1.68706552 |
| 23 | TGFBR2 | 1.66601474 |
| 24 | TEC | 1.65558967 |
| 25 | EEF2K | 1.63984054 |
| 26 | LRRK2 | 1.60607278 |
| 27 | CLK1 | 1.59341648 |
| 28 | SYK | 1.58879566 |
| 29 | LCK | 1.58221125 |
| 30 | HCK | 1.57127895 |
| 31 | IKBKB | 1.56901313 |
| 32 | MAP3K13 | 1.55064236 |
| 33 | TRIB3 | 1.51065976 |
| 34 | FES | 1.50300614 |
| 35 | FGFR4 | 1.48593019 |
| 36 | FGFR3 | 1.33209689 |
| 37 | SIK3 | 1.26809229 |
| 38 | MAP3K3 | 1.25156829 |
| 39 | CDK12 | 1.16598979 |
| 40 | TESK2 | 1.16115946 |
| 41 | BMPR2 | 1.15264041 |
| 42 | RIPK4 | 1.14497677 |
| 43 | PKN2 | 1.11928415 |
| 44 | PIM1 | 1.11894943 |
| 45 | NLK | 1.09918091 |
| 46 | MST4 | 1.08914134 |
| 47 | TAOK1 | 1.08810575 |
| 48 | MAP3K1 | 1.07129644 |
| 49 | LYN | 1.05633352 |
| 50 | MAP3K11 | 1.04154053 |
| 51 | PIK3CG | 1.02572227 |
| 52 | SIK2 | 1.00015627 |
| 53 | MARK3 | 0.99170410 |
| 54 | FGR | 0.96746919 |
| 55 | KDR | 0.95146591 |
| 56 | IRAK3 | 0.90875760 |
| 57 | MAP2K3 | 0.90798706 |
| 58 | TRPM7 | 0.90662535 |
| 59 | YES1 | 0.88538263 |
| 60 | MATK | 0.88409221 |
| 61 | KSR2 | 0.85745397 |
| 62 | PRKCH | 0.85363416 |
| 63 | JAK2 | 0.85141587 |
| 64 | CAMKK2 | 0.84755695 |
| 65 | TTN | 0.81815618 |
| 66 | CHUK | 0.81730916 |
| 67 | NME2 | 0.81413260 |
| 68 | RPS6KA4 | 0.80112829 |
| 69 | * PRKCQ | 0.76931032 |
| 70 | MAPK12 | 0.75927960 |
| 71 | PTK6 | 0.74207734 |
| 72 | MAPK7 | 0.74030456 |
| 73 | STK4 | 0.73827525 |
| 74 | TAOK3 | 0.73353023 |
| 75 | ALK | 0.70943556 |
| 76 | EPHA3 | 0.69948066 |
| 77 | PDGFRB | 0.68875349 |
| 78 | DMPK | 0.68715403 |
| 79 | TAOK2 | 0.68270449 |
| 80 | HIPK2 | 0.67315342 |
| 81 | CDC42BPA | 0.67025825 |
| 82 | CAMKK1 | 0.66246413 |
| 83 | CDK4 | 0.64067742 |
| 84 | IRAK2 | 0.63937908 |
| 85 | TNK2 | 0.63666655 |
| 86 | MAP3K6 | 0.63517787 |
| 87 | SMG1 | 0.62307380 |
| 88 | PTK2B | 0.61908830 |
| 89 | CDK6 | 0.61867059 |
| 90 | PDPK1 | 0.60996341 |
| 91 | PIM2 | 0.59261849 |
| 92 | NEK9 | 0.57822708 |
| 93 | PRKD2 | 0.56504798 |
| 94 | MAP3K5 | 0.54570678 |
| 95 | CAMK1D | 0.53892029 |
| 96 | MAP3K7 | 0.53646477 |
| 97 | BMX | 0.52931841 |
| 98 | PDK1 | 0.52176301 |
| 99 | GRK7 | 0.51809153 |
| 100 | RET | 0.50996133 |
| 101 | ABL1 | 0.50598950 |
| 102 | SGK3 | 0.50273125 |
| 103 | CAMK1G | 0.50228290 |
| 104 | MAP3K2 | 0.49954381 |
| 105 | CDK19 | 0.49143332 |
| 106 | EGFR | 0.48725962 |
| 107 | MAPKAPK2 | 0.47757997 |
| 108 | CDK9 | 0.46961292 |
| 109 | FYN | 0.46143304 |
| 110 | MAPK11 | 0.44328615 |
| 111 | MAP3K8 | 0.43177915 |
| 112 | SGK2 | 0.42446987 |
| 113 | PRKD1 | 0.41156432 |
| 114 | INSR | 0.40338877 |
| 115 | MELK | 0.39809633 |
| 116 | NEK2 | 0.39193198 |
| 117 | RAF1 | 0.38836220 |
| 118 | STK11 | 0.36097033 |
| 119 | RPS6KC1 | 0.34662654 |
| 120 | RPS6KL1 | 0.34662654 |
| 121 | STK24 | 0.33907345 |
| 122 | DYRK1B | 0.33362805 |
| 123 | RPS6KA5 | 0.31954179 |
| 124 | MAPK4 | 0.31937613 |
| 125 | RPS6KA6 | 0.31885469 |
| 126 | MARK2 | 0.30687946 |
| 127 | MAP2K6 | 0.29832186 |
| 128 | PKN1 | 0.29567257 |
| 129 | STK3 | 0.29221851 |
| 130 | IRAK1 | 0.29079146 |
| 131 | PAK4 | 0.28493577 |
| 132 | WNK1 | 0.28273923 |
| 133 | IGF1R | 0.27401067 |
| 134 | BRD4 | 0.23622876 |
| 135 | RIPK1 | 0.23354789 |
| 136 | PRKCD | 0.21971903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.61540151 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.69805817 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.59538357 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.42654051 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.42313447 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.40311555 |
| 7 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.38464507 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.35886490 |
| 9 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.26943348 |
| 10 | Measles_Homo sapiens_hsa05162 | 2.22504811 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.08215810 |
| 12 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.06564022 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.04350478 |
| 14 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.98875156 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.95659178 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74732159 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67455315 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66279702 |
| 19 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.66223316 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.65440517 |
| 21 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.62322968 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.62130614 |
| 23 | Shigellosis_Homo sapiens_hsa05131 | 1.61349253 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.61088779 |
| 25 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.58550545 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.56093620 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.42197685 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.41646770 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.40697248 |
| 30 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.39720401 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.39671695 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.37696184 |
| 33 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36870887 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.34069455 |
| 35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.32920344 |
| 36 | Hepatitis B_Homo sapiens_hsa05161 | 1.30385201 |
| 37 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28399713 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.28120615 |
| 39 | Platelet activation_Homo sapiens_hsa04611 | 1.26209221 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.23038314 |
| 41 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.21453299 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.19729786 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.19137200 |
| 44 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17603783 |
| 45 | Salmonella infection_Homo sapiens_hsa05132 | 1.17498630 |
| 46 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13028294 |
| 47 | Other glycan degradation_Homo sapiens_hsa00511 | 1.09083678 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.07736200 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.06564260 |
| 50 | Lysosome_Homo sapiens_hsa04142 | 1.01894900 |
| 51 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97885276 |
| 52 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93690805 |
| 53 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.87015443 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86934799 |
| 55 | Hepatitis C_Homo sapiens_hsa05160 | 0.86121842 |
| 56 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.85240489 |
| 57 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83957320 |
| 58 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.83909412 |
| 59 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.83566993 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81119963 |
| 61 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.80922418 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79432993 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79140736 |
| 64 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.78973146 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.78967227 |
| 66 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76001132 |
| 67 | * Endocytosis_Homo sapiens_hsa04144 | 0.73973492 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.72968783 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72941591 |
| 70 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.72392767 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72272109 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70474033 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.67196139 |
| 74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67187745 |
| 75 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64395304 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64051407 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60000272 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.59712192 |
| 79 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.58695462 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.57464458 |
| 81 | Prostate cancer_Homo sapiens_hsa05215 | 0.55773361 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55142256 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52022801 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51881755 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.51174315 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.50425049 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49585792 |
| 88 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48956761 |
| 89 | Ribosome_Homo sapiens_hsa03010 | 0.46970308 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46524717 |
| 91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46114341 |
| 92 | Pathways in cancer_Homo sapiens_hsa05200 | 0.46018858 |
| 93 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44393560 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44350930 |
| 95 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43982735 |
| 96 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41892541 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41622734 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.41540311 |
| 99 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40647734 |
| 100 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40008540 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.39308498 |
| 102 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.36939342 |
| 103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35904727 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33681688 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33366444 |
| 106 | Base excision repair_Homo sapiens_hsa03410 | 0.33286680 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32913313 |
| 108 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.31773654 |
| 109 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.30878552 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.30598850 |
| 111 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.29699878 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29616537 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.28940989 |

